covid-19 Clinical Trials and Research
Also known as: coronavirus disease 2019, sars-cov-2 infection, long covid, post-acute sequelae of sars-cov-2 infection (pasc), covid, novel coronavirus · ICD-10: U07.1
COVID-19 is an illness caused by the SARS-CoV-2 virus, affecting the respiratory system and other organs. Clinical trial research is actively exploring new treatments, improved vaccines, and ways to manage long-term symptoms. Find a Trial helps patients search for active studies on COVID-19.
Common questions about covid-19 clinical trials
What are the general requirements to participate in a COVID-19 clinical trial?
Eligibility criteria vary by study, but common factors include age, medical history, and current health status. Researchers use these criteria to ensure patient safety and collect meaningful data, as seen on ClinicalTrials.gov.
What are researchers currently investigating for COVID-19?
Current research on COVID-19 focuses on developing new antiviral medications, improved vaccines, and therapies for long COVID. Studies also explore better diagnostic tools and strategies to prevent severe illness, according to NIH RePORTER.
What are the different phases of COVID-19 clinical trials?
Clinical trials for COVID-19 progress through phases, starting with small safety studies (Phase 1) and expanding to larger groups to test effectiveness (Phases 2 and 3). Phase 4 studies monitor approved treatments in the general population, as detailed on ClinicalTrials.gov.
What types of interventions are being studied in COVID-19 trials?
Interventions in COVID-19 trials include antiviral drugs, monoclonal antibodies, anti-inflammatory medications, and various vaccine candidates. Researchers are also studying supportive care strategies and rehabilitation for long COVID symptoms, based on data from ClinicalTrials.gov.
Do clinical trials for COVID-19 cost money to participate in?
Generally, participants in clinical trials do not pay for study-related medical care or investigational treatments. Sponsors often cover these costs, and some trials may offer reimbursement for travel or other expenses, as noted on ClinicalTrials.gov.
Are there specific biomarkers researchers look at in COVID-19 trials?
Researchers often monitor biomarkers like C-reactive protein, D-dimer, and lymphocyte counts to assess inflammation and disease severity in COVID-19 trials. Viral load and antibody levels are also important for understanding immune response, according to NIH RePORTER.
What might prevent someone from joining a COVID-19 clinical trial?
Common exclusion criteria for COVID-19 trials might include certain pre-existing medical conditions, pregnancy, or recent participation in another study. These criteria help ensure participant safety and the integrity of the research, as listed on ClinicalTrials.gov.
Do COVID-19 clinical trials use placebos?
Many COVID-19 clinical trials, especially those testing new treatments or vaccines, use placebos to compare the investigational intervention against an inactive substance. This helps researchers determine if the treatment is truly effective, as explained on ClinicalTrials.gov.
How to find a covid-19 trial that fits you
- Describe your covid-19 situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.